Everything below concerns GLP-1 receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual incretin receptor agonist |
| Amino acid count | 39 residues | Includes non-natural residues |
| Approximate mass | 4.8 kDa | Reported values vary slightly by source |
| Fatty acid component | C20 diacid | Supports albumin binding |
| First US approval | 2022 | Glycemic indication, weight management followed |
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
=== Other uses in arts, entertainment, and media === Mass (2004 film), Indian Telugu-language film Mass (2021 film), American drama film Mass (novel), a 1973 novel by Filipino author F. Sionil José The Masses, a socialist magazine published in the US from 1911 to 1917
Cantrell had the band's engineer, Paul Figueroa, come in to his house and record a lot of his vocals and solos there. The band finished recording the album at the Henson Recording Studios in Los Angeles. Cantrell also said he expected the album to be released "probably sometime this summer." At the press room of the Rock and Roll Hall of Fame Induction Ceremony on April 14, 2018, Cantrell revealed that Alice in Chains had just signed with BMG, and that they had finished mixing their new album. Alice in Chains did not perform live in 2017. The band performed their first concert since October 2016 at the House of Blues in Boston on April 28, 2018. In May 2018, Alice in Chains headlined the festivals Carolina Rebellion, Lunatic Luau, Pointfest, Northern Invasion, the WMMR BBQ festival in Philadelphia, and the Rock on the Range festival in Columbus, Ohio on May 18, 2018, in which they paid tribute to Chris Cornell on the first anniversary of his death covering two Soundgarden songs to close their set, "Hunted Down" and "Boot Camp", respectively. At the end of the show, the lights on stage spelled out "CC" for Chris Cornell and "SG" for Soundgarden as feedback rang out. The band started their European tour in June 2018, and headlined the Tons Of Rock Festival in Norway alongside Ozzy Osbourne and Helloween. Alice in Chains are also scheduled to headline KISW's Pain in the Grass festival in August 2018. The band released a new single, "The One You Know", via Spotify, Amazon and iTunes on May 3, 2018. A music video directed by Adam Mason was released on YouTube the same day.
=== In the United Kingdom === Based on Appert's methods of food preservation, the tin can process was allegedly developed by Frenchman Philippe de Girard, who came to London and used British merchant Peter Durand as an agent to patent his own idea in 1810. Durand did not pursue food canning himself, selling his patent in 1811 to Bryan Donkin and John Hall, who were in business as Donkin Hall and Gamble, of Bermondsey. Bryan Donkin developed the process of packaging food in sealed airtight cans, made of tinned wrought iron. Initially, the canning process was slow and labour-intensive, as each large can had to be hand-made, and took up to six hours to cook, making canned food too expensive for ordinary people. The main market for the food at this stage was the British Army and Royal Navy. By 1817, Donkin recorded that he had sold £3000 (equal to £222,201 today) worth of canned meat in six months. In 1824, Sir William Edward Parry took canned beef and pea soup with him on his voyage to the Arctic in HMS Fury, during his search for a northwestern passage to India. In 1829, Admiral Sir James Ross also took canned food to the Arctic, as did Sir John Franklin in 1845. Some of his stores were found by the search expedition led by Captain (later Admiral Sir) Leopold McClintock in 1857.
Radio-controlled models – a popular hobby is playing with radio-controlled model boats, cars, airplanes, and helicopters (quadcopters) which are controlled by radio signals from a handheld console with a joystick. Most recent transmitters use the 2.4 GHz ISM band with multiple control channels modulated with PWM, PCM or FSK. Wireless doorbell – A residential doorbell that uses wireless technology to eliminate the need to run wires through the building walls. It consists of a doorbell button beside the door containing a small battery powered transmitter. When the doorbell is pressed it sends a signal to a receiver inside the house with a speaker that sounds chimes to indicate someone is at the door. They usually use the 2.4 GHz ISM band. The frequency channel used can usually be changed by the owner in case another nearby doorbell is using the same channel.
regulon A group of non-contiguous genes which are regulated as a unit, generally by virtue of having their expression controlled by the same regulatory element or set of elements, e.g. the same repressor or activator. The term is most commonly used with prokaryotes, where a regulon may consist of genes from multiple operons.
Sources: en.wikipedia.org
Magnetic reconnection in highly conductive systems is important because it concentrates energy in time and space, such that gentle forces applied to a plasma over long periods of time can cause violent explosions and bursts of radiation. When the fluid cannot be considered completely conductive, but the other conditions for ideal MHD are satisfied, it is possible to use an extended model called resistive MHD. This includes an extra term in Ohm's law that models the collisional resistivity. Generally, MHD computer simulations are at least somewhat resistive because their computational grid introduces a numerical resistivity.
=== 17 June === Ukraine launched a drone attack on western Russia, with the HUR claiming to have struck a metallurgical plant and military production facilities in Belgorod, Voronezh, and Lipetsk Oblasts. The Russian Investigative Committee charged Ukrainian Colonel Mykola Dzyaman with terrorism in absentia and placed him on a wanted list for ordering the shooting down of a A-50U over the Sea of Azov on 23 February 2024.
Furrydom's Storyteller: Uncle Kage – personal website Samuel Conway's Journal – journal Samuel Conway on X Uncle Kage at WikiFur Articles at WikiFur: Uncle Kage's Story Hour, ConClave, Sofawolf Press, Anthrolations, HistoriMorphs, Synnabar
is the compartment used for the individuals of the population who have been infected and then removed from the disease, either due to immunization or due to death. Those in this category are not able to be infected again or to transmit the infection to others. The flow of this model may be considered as follows:
Sources: en.wikipedia.org
Experts anticipate that future microfluidic-based innovations for directed evolution campaigns will be driven in the commercial space, resulting in more simple and less expensive methods and tools that can be applied to biotechnologically-relevant enzymes.
=== Chemistry === Lonicera japonica leaves contain methyl caffeate, 3,4-di-O-caffeoylquinic acid, methyl 3,4-di-O-caffeoylquinic acid, protocatechuic acid, methyl chlorogenic acid, and luteolin. Other polyphenols present in the plant are hyperoside and caffeic acid. The two secoiridoid glycosides, loniceracetalides A and B, can be isolated, together with 10 known iridoid glycosides, from the flower buds.
Finance and Provisions – responsible for supplying provisions and other necessities to the guerrillas. Organization and Communication – responsible for coordinating the relationship between the leadership and its support base. Military Committee – responsible for the guerrilla's army regiments. Intelligence and Education – responsible for political education and information on enemy activity, and United Front – responsible for propaganda and mobilizing support. The Huk military structure was modeled after the Chinese Red Army. It was composed of squads and platoons, consisting of 100 officers and men, which formed a squadron. Two squadrons formed one battalion, and two battalions formed a regiment. These numbers were not always followed though: For example, Squadron 8, based in Talavera, Nueva Ecija, had twelve squads, each with a dozen men.
Sources: en.wikipedia.org
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.
United States approval for type 2 diabetes was granted in 2022, and a chronic weight management indication was added later. Approval timelines differ across other jurisdictions. Earlier human data came from phase 1 and phase 2 trials published before those decisions.
Native hormones are short-lived peptides that enzymes degrade within minutes. Tirzepatide carries non-natural residues and a fatty acid chain that resist this breakdown and extend circulation time. The result is a longer interval between administrations than the natural hormones could support.
It is a dual GIP and GLP-1 receptor agonist, frequently grouped with incretin-based peptide therapeutics. It is a peptide rather than a small molecule and is given by subcutaneous injection.